Cost of Revenue Comparison: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.

Biotech Cost Dynamics: PTC vs. Xenon

__timestamp	PTC Therapeutics, Inc.	Xenon Pharmaceuticals Inc.
Wednesday, January 1, 2014	79838000	5903000
Thursday, January 1, 2015	121816000	2762000
Friday, January 1, 2016	117633000	1114000
Sunday, January 1, 2017	4577000	25573000
Monday, January 1, 2018	12670000	6000000
Tuesday, January 1, 2019	12135000	38845000
Wednesday, January 1, 2020	18942000	50523000
Friday, January 1, 2021	32328000	75463000
Saturday, January 1, 2022	44678000	105767000
Sunday, January 1, 2023	65486000	167512000

Unleashing insights

Cost of Revenue: A Tale of Two Biotechs

In the competitive landscape of biotechnology, understanding cost structures is crucial. PTC Therapeutics, Inc. and Xenon Pharmaceuticals Inc. offer a fascinating comparison. From 2014 to 2023, PTC Therapeutics saw a fluctuating cost of revenue, peaking in 2015 with a 50% increase from the previous year. Meanwhile, Xenon Pharmaceuticals experienced a dramatic rise, with costs surging by over 2,700% from 2014 to 2023. This stark contrast highlights differing business strategies and market conditions.

Key Insights

PTC Therapeutics: After a peak in 2015, costs stabilized, reflecting strategic adjustments.
Xenon Pharmaceuticals: A steady upward trend, particularly post-2017, suggests aggressive expansion or increased operational activities.
This data underscores the dynamic nature of biotech financials, where strategic decisions and market forces shape cost trajectories.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Cost of Revenue: Key Insights for Novo Nordisk A/S and Xenon Pharmaceuticals Inc.

Cost of Revenue: Key Insights for Intra-Cellular Therapies, Inc. and PTC Therapeutics, Inc.

Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc.'s Expenses

Jazz Pharmaceuticals plc vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored

Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.

Cost of Revenue Comparison: PTC Therapeutics, Inc. vs Bausch Health Companies Inc.

Analyzing Cost of Revenue: PTC Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.

Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Mesoblast Limited

PTC Therapeutics, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored

PTC Therapeutics, Inc. vs Evotec SE: Efficiency in Cost of Revenue Explored

Xenon Pharmaceuticals Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored

Comparing Cost of Revenue Efficiency: Xenon Pharmaceuticals Inc. vs MiMedx Group, Inc.